Literature DB >> 18224422

ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.

U Koehl1, K Bochennek, R Esser, A Brinkmann, R Quaritsch, M Becker, J Soerensen, P Bader, D Schwabe, T Klingebiel, J Fischer, S Y Zimmermann.   

Abstract

Considering the growing use of immunotherapeutic strategies in paediatric stem cell transplantation associated with risk of graft-versus-host disease, an accurate method for the enumeration of residual T cells/kg recipient's body weight is of paramount importance. Therefore, we propose a multi colour-flow cytometric strategy for correct absolute vital T cell enumeration in manipulated cell preparations for clinical use. The gating strategy is based on the ISHAGE single-platform stem cell enumeration method in combination with experiences from lymphocyte subtyping, using low scatter, high expression of CD3 and CD45 antigens and 7-AAD staining in a no-wash-preparation with counting beads. In spiking experiments, the detection limit was determined to be at 0.7 +/- 0.5 CD3(+) cells/microl with a minimum of 50 T cell events acquired. The cell preparations analysed contained a median absolute CD3(+) T cell number of 221 x 10(3) (0.09%, CD34 selected grafts, n = 187), 900 x 10(3) (0.004%, CD3/CD19 depleted grafts, n = 15) and 283 x 10(3) (0.012%, CD3 depleted/CD56 enriched NK-cells, n = 14), respectively. The results differed of those from conventional T cell measurement in cell products after extensive manipulation. Our method provides reliable residual T cell enumeration even at extremely low concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18224422     DOI: 10.1007/s12185-007-0018-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  31 in total

1.  Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward.

Authors:  D Barnett; V Granger; L Whitby; I Storie; J T Reilly
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

2.  Multicentre evaluation of stable reference whole blood for enumeration of lymphocyte subsets by flow cytometry.

Authors:  Cherry Edwards; Danielle Belgrave; George Janossy; Nicholas J Bradley; Richard Stebbings; Rose Gaines-Das; Robin Thorpe; Alex Sawle; Maria Jorge Arroz; Bruno Brando; Jan Willem Gratama; Alberto Orfao de Matos; Stephano Papa; Michael Papamichail; Rodica Lenkei; Gregor Rothe; David Barnett
Journal:  Cytometry B Clin Cytom       Date:  2005-06-22       Impact factor: 3.058

3.  Automated cell count in flow cytometry: a valuable tool to assess CD4 absolute levels in peripheral blood.

Authors:  M C Béné; M N Kolopp Sarda; J El Kaissouni; A De March Kennel; C Molé; C Kohler; G C Faure
Journal:  Am J Clin Pathol       Date:  1998-09       Impact factor: 2.493

4.  Comparative analysis of whole blood lysis methods for flow cytometry.

Authors:  X Bossuyt; G E Marti; T A Fleisher
Journal:  Cytometry       Date:  1997-06-15

5.  Cryopreservation of human lymphocytes for assessment of lymphocyte subsets and natural killer cytotoxicity.

Authors:  S Fujiwara; M Akiyama; M Yamakido; T Seyama; K Kobuke; M Hakoda; S Kyoizumi; S L Jones
Journal:  J Immunol Methods       Date:  1986-06-24       Impact factor: 2.303

Review 6.  Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.

Authors:  B Brando; D Barnett; G Janossy; F Mandy; B Autran; G Rothe; B Scarpati; G D'Avanzo; J L D'Hautcourt; R Lenkei; G Schmitz; A Kunkl; R Chianese; S Papa; J W Gratama
Journal:  Cytometry       Date:  2000-12-15

7.  The influence of cryopreservation on cytokine production by human T lymphocytes.

Authors:  S Y Wang; M L Hsu; C H Tzeng; H C Hsu; C K Ho
Journal:  Cryobiology       Date:  1998-08       Impact factor: 2.487

8.  Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes.

Authors:  Jan W Gratama; Jaco Kraan; Mike Keeney; Viv Granger; David Barnett
Journal:  Cytometry       Date:  2002-04-15

9.  Susceptibility of human T cells, T-cell subsets, and B cells to cryopreservation.

Authors:  M Venkataraman; M P Westerman
Journal:  Cryobiology       Date:  1986-06       Impact factor: 2.487

Review 10.  Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.

Authors:  Ernst Holler
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

View more
  7 in total

1.  An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy.

Authors:  Isabel Vogler; Sebastian Newrzela; Sylvia Hartmann; Nadine Schneider; Dorothee von Laer; Ulrike Koehl; Manuel Grez
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

2.  Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.

Authors:  Andromachi Scaradavou; Katherine M Smith; Rebecca Hawke; Allison Schaible; Michelle Abboud; Nancy A Kernan; James W Young; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-22       Impact factor: 5.742

3.  Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.

Authors:  Sylvia Borchers; Melanie Bremm; Thomas Lehrnbecher; Elke Dammann; Brigitte Pabst; Benno Wölk; Ruth Esser; Meral Yildiz; Matthias Eder; Michael Stadler; Peter Bader; Hans Martin; Andrea Jarisch; Gisbert Schneider; Thomas Klingebiel; Arnold Ganser; Eva M Weissinger; Ulrike Koehl
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

4.  IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.

Authors:  Claudia Brehm; Sabine Huenecke; Andrea Quaiser; Ruth Esser; Melanie Bremm; Stephan Kloess; Jan Soerensen; Hermann Kreyenberg; Christian Seidl; Petra S A Becker; Heiko Mühl; Thomas Klingebiel; Peter Bader; Jakob R Passweg; Dirk Schwabe; Ulrike Koehl
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

5.  Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study.

Authors:  Emilia Salzmann-Manrique; Melanie Bremm; Sabine Huenecke; Milena Stech; Andreas Orth; Matthias Eyrich; Ansgar Schulz; Ruth Esser; Thomas Klingebiel; Peter Bader; Eva Herrmann; Ulrike Koehl
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

6.  Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.

Authors:  Olaf Oberschmidt; Michael Morgan; Volker Huppert; Joerg Kessler; Tanja Gardlowski; Nadine Matthies; Krasimira Aleksandrova; Lubomir Arseniev; Axel Schambach; Ulrike Koehl; Stephan Kloess
Journal:  Hum Gene Ther Methods       Date:  2019-05-16       Impact factor: 2.396

7.  Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol.

Authors:  Ulrike Koehl; Claudia Brehm; Sabine Huenecke; Stefanie-Yvonne Zimmermann; Stephan Kloess; Melanie Bremm; Evelyn Ullrich; Jan Soerensen; Andrea Quaiser; Stephanie Erben; Claudia Wunram; Tanja Gardlowski; Eileen Auth; Torsten Tonn; Christian Seidl; Sandrine Meyer-Monard; Martin Stern; Jakob Passweg; Thomas Klingebiel; Peter Bader; Dirk Schwabe; Ruth Esser
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.